MedPath

Case Collection Study to Support Digital Mammography Image Software Change

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Device: Mammography screening and diagnosis
Registration Number
NCT00756496
Lead Sponsor
Siemens Medical Solutions USA - CSG
Brief Summary

The primary objective of this study is to compare image processing software to support a new image processing software application for a full-field digital mammography (FFDM) system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
442
Inclusion Criteria
  • Female
  • > 40 years
Exclusion Criteria
  • Pregnant women, or women who may become pregnant
  • Mammographic evidence of breast surgery, prior radiation to the breast, needle projection or pre-biopsy markings are evident in the mammogram (but may include breast implants)
  • Palpable lesion or one that is visible by another modality
  • Inmates

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Mammography screening and diagnosis-
Primary Outcome Measures
NameTimeMethod
Area Under the Receiver Operating Characteristic (ROC) Curve to Compare Diagnostic Accuracy of 2 Algorithms in Breast Cancer Diagnosis~1 year. Women with negative or biopsy benign findings at baseline (study entry) were followed for 1 year to confirm the negative status at 1-year follow-up mammography exam. Women diagnosed with cancer were not followed up.

The primary objective of this study was to demonstrate non-inferiority of the Siemens' processing algorithm to Lorad's processing algorithm with regards to readers' diagnostic accuracy in detecting and characterizing breast lesions. The non-inferiority analyses were performed by comparing the area under the ROC curve (AUC) for the two algorithms \& to compare false positive marks per subject.

The ROC curve incorporates both sensitivity (true positive rate) and specificity (true negative rate) providing a single assessment incorporating both measures. It shows in a graphical way the trade-off between clinical sensitivity and specificity for every possible cut-off for a test, and gives an idea about the benefit of using the test in question. The higher the total area under the curve, the greater the predictive power of the reader assessments.

A breast-based analysis was used for the primary AUC comparison in order to obtain additional power by having more normal/benign breasts.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath